Activase May Be Reclassified With Separate DRG Under Medicare Part A
Executive Summary
The Centers for Medicare & Medicaid Services is considering the creation of a separate diagnosis-related group for the use of drugs like Genentech's Activase to treat ischemic strokes under Medicare Part A